Peluvi fares well in analgesic/anti-inflammatory market
Sales of Daewon’s felubiprofen reached over 2.0 billion won since its release in October 2008, making it one of the top-selling drugs in the country.
Felubiprofen is Korea’s ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
